SCHEMBL5386466

SCHEMBL5386466

N[C@@H]1C[C@H](N)CN(c2nc(Nc3nc4ccc([N+](=O)[O-])cc4s3)nc(N3C[C@H](N)C[C@H](N)C3)n2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
CYP3A4 P08684 1/20 0.48
TSHR P16473 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
DYRK1A Q13627 1/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
MAPT P10636 2/20 0.46
NPC1 O15118 5/20 0.46
RAB9A P51151 4/20 0.46
APOBEC3A P31941 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
RIPK1 Q13546 1/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
RXFP1 Q9HBX9 1/20 0.44
PKM P14618 1/20 0.44
POLB P06746 1/20 0.44
STAT1 P42224 1/20 0.44
MCL1 Q07820 1/20 0.44
ACP1 P24666 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14504510 0.83 NPC1 (0.61) ALDH1A1CYP3A4TSHRTDP1DYRK1A
SCHEMBL5390790 0.82 CLK1 (0.51) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL5387324 0.80 NPC1 (0.50) ALDH1A1CYP3A4TSHRKMT2AMEN1
SCHEMBL5387635 0.78 MEN1 (0.59) ALDH1A1TDP1KMT2AMEN1MAPT
SCHEMBL5380654 0.77 GAA (0.58) ALDH1A1CYP3A4TDP1KMT2AMEN1
SCHEMBL5401058 0.77 CTSL (0.54) ALDH1A1KMT2AMEN1MAPTSMN1; SMN2
SCHEMBL5387698 0.75 GAA (0.43) ALDH1A1TDP1KMT2AMEN1MAPT
SCHEMBL5392856 0.73 KMT2A (0.55) ALDH1A1CYP3A4TDP1KMT2AMEN1
SCHEMBL12558910 0.72 ALDH1A1 (0.47) ALDH1A1DYRK1AKMT2AMEN1MAPT
SCHEMBL2116582 0.71 DYRK1A (0.67) ALDH1A1CYP3A4TSHRTDP1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7223759-B2 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds ANADYS PHARMACEUTICALS, INC. (US) 2007-05-29 US claimed
US-20070197533-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds ANADYS PHARMACEUTICALS, INC. (US) 2007-08-23 US disclosed
US-20070197533-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds ANADYS PHARMACEUTICALS, INC. (US) 2007-08-23 US disclosed
US-7223759-B2 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds ANADYS PHARMACEUTICALS, INC. (US) 2007-05-29 US disclosed
US-20050239827-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compouds ANADYS PHARMACEUTICALS, INC. 2005-10-27 US disclosed
WO-2005028467-A1 ANTIBACTERIAL 3,5-DIAMINOPIPERIDINE-SUBSTITUTE AROMATIC AND HETEROAROMATIC COMPOUNDS ANADYS PHARMACEUTICALS, INC. (US) 2005-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197533-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds DDC, DPP3, AMPD3 ALDH1A1 2233/4885CYP3A4 812/4885TSHR 4325/4885
US-20050239827-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compouds AMPD3, AAAS, PEPD ALDH1A1 2096/4885CYP3A4 650/4885TSHR 3906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.